ATE408685T1 - Antimikrobielle peptide, abstammend von ubiquicidin - Google Patents

Antimikrobielle peptide, abstammend von ubiquicidin

Info

Publication number
ATE408685T1
ATE408685T1 AT98925978T AT98925978T ATE408685T1 AT E408685 T1 ATE408685 T1 AT E408685T1 AT 98925978 T AT98925978 T AT 98925978T AT 98925978 T AT98925978 T AT 98925978T AT E408685 T1 ATE408685 T1 AT E408685T1
Authority
AT
Austria
Prior art keywords
ubiquicidine
instance
peptides derived
antimicrobial peptides
peptide
Prior art date
Application number
AT98925978T
Other languages
English (en)
Inventor
Petrus Nibbering
Pieter Hiemstra
Maria Theodora Van D Barselaar
Ernest Pauwels
Rolf Feitsma
Original Assignee
Univ Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leiden filed Critical Univ Leiden
Application granted granted Critical
Publication of ATE408685T1 publication Critical patent/ATE408685T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT98925978T 1997-05-29 1998-05-29 Antimikrobielle peptide, abstammend von ubiquicidin ATE408685T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1006164A NL1006164C2 (nl) 1997-05-29 1997-05-29 Antimicrobiële peptiden.

Publications (1)

Publication Number Publication Date
ATE408685T1 true ATE408685T1 (de) 2008-10-15

Family

ID=19765050

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98925978T ATE408685T1 (de) 1997-05-29 1998-05-29 Antimikrobielle peptide, abstammend von ubiquicidin

Country Status (8)

Country Link
US (1) US6884776B1 (de)
EP (1) EP1003854B1 (de)
AT (1) ATE408685T1 (de)
AU (1) AU7791398A (de)
CA (1) CA2291894A1 (de)
DE (1) DE69840024D1 (de)
NL (1) NL1006164C2 (de)
WO (1) WO1998054314A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2296160C2 (ru) * 2001-02-23 2007-03-27 ДСМ Ай Пи ЭССЕТС Б.В. Новые гены, кодирующие новые протеолитические ферменты
US7603239B2 (en) * 2004-05-05 2009-10-13 Massachusetts Institute Of Technology Methods and systems for generating peptides
WO2006065977A2 (en) 2004-12-15 2006-06-22 The Regents Of The University Of Colorado Antimicrobial peptides and methods of use
EP2346521A4 (de) * 2008-10-06 2012-06-20 Univ Colorado Regents Peptide und verwendungsverfahren dafür
EP2204377A1 (de) * 2008-12-30 2010-07-07 Commissariat à l'énergie atomique et aux énergies alternatives Cysteinfreie, Technetium- oder Rhenium-chelatisierende Peptidsequenzen und deren Verwendung
WO2010141760A2 (en) * 2009-06-05 2010-12-09 The Regents Of The University Of Colorado, A Body Corporate Antimicrobial peptides
EP3384938A1 (de) 2011-09-12 2018-10-10 Moderna Therapeutics, Inc. Manipulierte nukleinsäuren und verfahren zur verwendung davon
HK1206612A1 (en) 2012-04-02 2016-01-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of secreted proteins
EP2834259A4 (de) 2012-04-02 2016-08-24 Moderna Therapeutics Inc Modifizierte polynukleotide
GB201420222D0 (en) * 2014-11-13 2014-12-31 Univ Edinburgh Molecular probes and methods using the same
GB201420221D0 (en) * 2014-11-13 2014-12-31 Univ Edinburgh Molecular probes and methods using the same
EP3374391B1 (de) 2015-11-10 2024-04-17 Visterra, Inc. Antikörpermolekülarzneimittelkonjugate die an lipopolysaccharide binden und verwendungen davon
JP7303110B2 (ja) 2017-01-18 2023-07-04 ビステラ， インコーポレイテッド 抗体分子－薬物コンジュゲートおよびその使用
US11969476B2 (en) 2020-04-03 2024-04-30 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof
KR102569795B1 (ko) * 2021-05-03 2023-08-23 경상국립대학교산학협력단 강도다리에서 유래한 유비퀴틴 관련 신규 항균 펩티드 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0639082B1 (de) * 1990-04-17 1998-09-09 Mallinckrodt Medical, Inc. Methode und reagentien um technetium-99m-komplexe herzustellen
JP3009498B2 (ja) * 1991-03-28 2000-02-14 日清製粉株式会社 脂質分解酵素阻害剤
JPH08176193A (ja) * 1994-12-23 1996-07-09 Soosei:Kk 長期増強誘導性ペプチド
US6319503B1 (en) * 1998-02-19 2001-11-20 Proteinix Company Heat shock fusion-based vaccine system

Also Published As

Publication number Publication date
DE69840024D1 (de) 2008-10-30
NL1006164C2 (nl) 1998-12-01
CA2291894A1 (en) 1998-12-03
EP1003854B1 (de) 2008-09-17
EP1003854A1 (de) 2000-05-31
US6884776B1 (en) 2005-04-26
WO1998054314A1 (en) 1998-12-03
AU7791398A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
ATE408685T1 (de) Antimikrobielle peptide, abstammend von ubiquicidin
BR0010720A (pt) Peptìdeos de neisseria antigênicos
ATE218579T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin- analogen
DE69838143D1 (de) Antimikrobielle peptide
WO1995021919A3 (en) Protein having tpo activity
CY1108049T1 (el) Πεπτιδια με βαση την αλληλουχια της ανθρωπινης λακτοφερρινης και χρηση τους
ATE211391T1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
WO2002101052A3 (en) Salutaridinol 7-o-acetyltransferase and derivatives thereof
CY1109946T1 (el) Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων
ATE362939T1 (de) Dimere von thrombinpeptidderivaten
DE69940927D1 (de) PEPTIDFRAGMENTE MIT DEN ZELLTOD VERHINDERNDEr AKTIVITÄT
DE69837265D1 (de) Polypeptide zur regenerierung des nervensystems
DE68905097D1 (de) Peptid-molekuele, wirksam gegen gram-positive keime.
EE200000478A (et) Peptiid, seda kodeeriv geen, diagnostiline reagent ja diagnostiline reaktiivikomplekt ning vaktsiinkasutamiseks riketsioosi ravis
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
DE69623803D1 (de) Verwendung von KASEINFRAGMENTEn als WACHSTUMERFÖRDERer
DE69827880D1 (de) Iga1-protease fragment als trägerpeptid
WO2005005469A3 (en) Novel purified polypeptides from staphylococcus aureus
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
WO2004011638A3 (en) Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures
WO2002100897A3 (fr) Complexes moleculaires brca1/acc alpha, applications diagnostiques et therapeutiques
WO2004058811A3 (en) Crystal structures of yhhf polypeptides
WO2003027274A3 (en) Purified polypeptides from pseudomonas aeruginosa
WO2004041856A3 (en) Crystal structures of bacterial inorganic pyrophosphatases

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1003854

Country of ref document: EP

REN Ceased due to non-payment of the annual fee